Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Hemophilia Federation of America (HFA) shared a reminder post on X:
”Time is running out to register!
Join us tomorrow, July 29 ,at 7pm ET for Living with Hemophilia B: From Challenges to Hopeful Futures, an interactive virtual event presented in partnership with Novo Nordisk.”
Register now.
In collaboration with Novo Nordisk, the Hemophilia Federation of America (HFA) will host a virtual presentation on July 29 at 7 p.m. EST, led by Dr. Robert Sidonio.
This interactive session will explore the everyday challenges faced by individuals living with hemophilia B and provide a platform for open dialogue around personal experiences, treatment roadblocks, and future hopes for disease management.
With a focus on community engagement and patient-centered care, the event aims to foster shared understanding and highlight evolving needs in hemophilia B care.
Do not miss any conference or webinar on hemophilia management, read Hemostasis Today.
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage